Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Eql Pharma AB

Closing information (x1000 SEK)

Closing information 2024/03 (consolidated) 2023/03 (consolidated) 2022/03 (consolidated)
Turnover 264,168 Less Arrow 259,913 More Arrow 409,753
Financial expenses 5,732 Less Arrow 2,372 More Arrow 2,874
Earnings before taxes 28,604 More Arrow 38,968 Less Arrow 35,965
EBITDA 41,374 More Arrow 49,625 Less Arrow 45,018
Total assets 373,759 Less Arrow 285,696 Less Arrow 237,888
Current assets 197,774 Less Arrow 167,228 Less Arrow 123,452
Current liabilities 162,050 Less Arrow 115,976 Less Arrow 98,757
Equity capital 177,726 Less Arrow 154,753 Less Arrow 123,626
- share capital 1,308 Equal arrow 1,308 Equal arrow 1,308
Employees (average) 21 Less Arrow 18 Less Arrow 13

Financial ratios

Fiscal year 2024/03 (consolidated) 2023/03 (consolidated) 2022/03 (consolidated)
Solvency 47.6% More Arrow 54.2% Less Arrow 52.0%
Turnover per employee 12,579 More Arrow 14,440 More Arrow 31,519
Profit as a percentage of turnover 10.8% More Arrow 15.0% Less Arrow 8.8%
Return on assets (ROA) 9.2% More Arrow 14.5% More Arrow 16.3%
Current ratio 122.0% More Arrow 144.2% Less Arrow 125.0%
Return on equity (ROE) 16.1% More Arrow 25.2% More Arrow 29.1%
Change turnover 4,255 Less Arrow -149,840 More Arrow 230,612
Change turnover % 2% Less Arrow -37% More Arrow 129%
Chg. No. of employees 3 More Arrow 5 Less Arrow 3
Chg. No. of employees % 17% More Arrow 38% Less Arrow 30%

Total value of public sale

Fiscal year 2024/03 (consolidated) 2023/03 (consolidated) 2022/03 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.